ACTA PHARMACOLOGICA SINICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2023-01-31 ms8000000053730142 来自江苏省

已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2021-04-15 1210939fm82(暂无昵称)

审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0
偏重的研究方向：药物;肠道菌群
经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备

114 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-09-29 ms8000002049264795

审稿速度:1.0 | 投稿命中率:25.0
经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿

45 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-12-09 Small Fish 来自江苏省

偏重的研究方向：药理学;肿瘤药理学
经验分享：请问大家投稿以后多久分配编辑？

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-01-12 卡球球 zhao

请问APS收中药复方药理研究吗？

67 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-06-26 qiuaaaaaa

偏重的研究方向：中药单体;肿瘤
经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态

63 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-06-30 124fe17cm60(暂无昵称)

有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-11-03 lsdxixi

偏重的研究方向：药理学
经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-05-04 努力发光

补充信息中 read me 怎么写呢？哭了

66 0

[GetPortalCommentsPageByObjectIdResponse(id=2112414, encodeId=f541211241495, content=已经Awaiting Reviewer Assignment15天了，前面分配编辑和under review都很快，为什么审稿人这么难找呀，是因为这段时间过年吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Jan 31 17:10:01 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=957330, encodeId=e11995e3300b, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:150.0 偏重的研究方向：药物;肠道菌群 经验分享：中科院药物所所办的杂志，对中国人友好。审稿1个多月就一审意见返回。总共两个审稿人。审稿人很细致严谨，给了大修，补实验补了两个月，大修修回后直接接收。总的来说是一个性价比很高的杂志，从3分-4分-5分一路涨上来，口碑很好，建议有一定内容的文章可以投稿这个杂志。不过审稿人会要求wb的原图，建议做好心理准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=069b2223182, createdName=1210939fm82(暂无昵称), createdTime=Thu Apr 15 16:39:32 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091084, encodeId=aeac209108496, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：提交时需要wb原始条带，审稿速度非常快，2周，然后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bdb5493020, createdName=ms8000002049264795, createdTime=Thu Sep 29 21:00:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105156, encodeId=e996210515615, content=偏重的研究方向：药理学;肿瘤药理学 经验分享：请问大家投稿以后多久分配编辑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=Small Fish, createdTime=Fri Dec 09 23:08:16 CST 2022, time=2022-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1183497, encodeId=1a94118349e62, content=请问APS收中药复方药理研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jan 12 13:02:39 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228709, encodeId=b0e91228e0998, content=偏重的研究方向：中药单体;肿瘤 经验分享：有没有最近投稿的小伙伴，大约多久可以分配编辑呀，我投稿三天了还是原始状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220429/1b930e3e884045ab8014c5d96c660c2a/9236b11a0fb04f98ab3cf26c46002241.jpg, createdBy=4a5f5633915, createdName=qiuaaaaaa, createdTime=Sun Jun 26 09:13:41 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229768, encodeId=ce0d1229e6897, content=有没有最近投的小伙伴，这个杂志现在投编辑受理，一审速度要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb322530388, createdName=124fe17cm60(暂无昵称), createdTime=Thu Jun 30 19:02:31 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098213, encodeId=a4b1209821344, content=偏重的研究方向：药理学 经验分享：今天刚发现这个这么好的期刊，但是找了半天没找到官网地址，好心人分享一下网址吧，谢谢大牛们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0d4709779, createdName=lsdxixi, createdTime=Thu Nov 03 12:53:01 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216825, encodeId=d30912168254a, content=补充信息中 read me 怎么写呢？哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 16:47:12 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216843, encodeId=ad7712168436e, content=这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c446402467, createdName=努力发光, createdTime=Wed May 04 17:29:15 CST 2022, time=2022-05-04, status=1, ipAttribution=)]

2022-05-04 努力发光

这个杂志补充信息中需要提供一份“read me”文件，大致怎么写呢？

70 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务